WELLBIOTEC CO.,LTD
KRX
✓Strengths
- Moderate debt: debt-to-equity of 0.81.
- Current assets comfortably cover current liabilities (current ratio 1.8).
!Watch-points
- Thin interest cover: operating profit covers interest only about -13.6 times.
- Return on equity is on the lower side at -60.9%.
- Return on capital employed is on the lower side at -19.7%.
- The company reported a net loss in the latest period.
- Sales growth has been slow over five years (about -1% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
-8.35
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
2 / 4
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 4 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 139.00
Dividend Yield0.00%
ROCE-19.70%
ROE-60.94%
Debt to Equity0.81
Current Ratio1.80
EPS₩ -84.70
PAT Margin-9.87%
ICR-13.57
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity